Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: The prostate 81.2021, 12, S. 874-881. doi:10.1002/pros.24184, ISSN 1097-0045
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2021
- Creator
-
Wenzel, Mike
Würnschimmel, Christoph
Ruvolo, Claudia C.
Nocera, Luigi
Tian, Zhe
Saad, Fred
Briganti, Alberto
Tilki, Derya
Graefen, Markus
Kluth, Luis
Mandel, Philipp
Chun, Felix
Karakiewicz, Pierre I.
- URN
-
urn:nbn:de:hebis:30:3-639269
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wenzel, Mike
- Würnschimmel, Christoph
- Ruvolo, Claudia C.
- Nocera, Luigi
- Tian, Zhe
- Saad, Fred
- Briganti, Alberto
- Tilki, Derya
- Graefen, Markus
- Kluth, Luis
- Mandel, Philipp
- Chun, Felix
- Karakiewicz, Pierre I.
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2021
Other Objects (12)
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Hüftkappenendoprothesen : Einzelstrukturanalyse und Dokumentation alter Wagnerkappen als Basis für die Interpretation des modernen Hüftkopfoberflächenersatzes
Complication rates after trus guided transrectal systematic and mri-targeted prostate biopsies in a high-risk region for antibiotic resistances
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients
Editorial: Sequelae of prostate cancer therapy: Avoidance strategies and management options
Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Hüftkappenendoprothesen : Einzelstrukturanalyse und Dokumentation alter Wagnerkappen als Basis für die Interpretation des modernen Hüftkopfoberflächenersatzes
Complication rates after trus guided transrectal systematic and mri-targeted prostate biopsies in a high-risk region for antibiotic resistances
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients
Editorial: Sequelae of prostate cancer therapy: Avoidance strategies and management options
Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Hüftkappenendoprothesen : Einzelstrukturanalyse und Dokumentation alter Wagnerkappen als Basis für die Interpretation des modernen Hüftkopfoberflächenersatzes
Complication rates after trus guided transrectal systematic and mri-targeted prostate biopsies in a high-risk region for antibiotic resistances
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients
Editorial: Sequelae of prostate cancer therapy: Avoidance strategies and management options
Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out